Cancer Drug Prices Vary by 338% in Europe, Australia and New Zealand
As per new research published in The Lancet Oncology, the price of new cancer drugs varies by widely by 338% in high-income countries like Europe, Australia and New Zealand. According to sources, the UK and Mediterranean countries like Greece, Spain and Portugal pay the lowest average unit manufacturer prices for a group of 31 originator cancer drugs whereas Sweden, Switzerland, and Germany pay the highest prices. Out of 31 drugs, none had a unit price lower than €10. Four drugs (13%) had an average unit manufacturer price between €250 an......
- SUR LE MEME SUJET
FDA approves Baxalta's drug for rare bleeding disorder - Reuters
UNICANCER to perform an initial assessment of the use of new French methods of certification in the French Cancer Centers during the 32nd Conference of the international Society for Quality in Healthcare (ISQua) in Doha - Qat - unicancer
(Reuters) - Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo. The drugmaker’s late-stage trial testing Nuplazid, stopped in September after positive results, enrolled 392 patients aged 74.5 years on average. Patients on the drug experienced a 65% reduction rate in relapses of dementia-related psychotic episodes, the company said. Chief Executive Officer Stephen Davis said Acadia planned to meet with the U.S. regulat... ...
MELBOURNE (Reuters) - Deaths related to measles, mostly among small children, have more than tripled to 20 in the past week on the Pacific island of Samoa, the government has said eight days after declaring a state of emergency over the outbreak. The island state of just 200,000, located south of the equator and half way between Hawaii and New Zealand, declared a measles epidemic late in October after the first deaths. The government has identified 1,644 suspected cases of measles, more than doubling over the past week, with deaths rising... ...
MELBOURNE (Reuters) - Samoa declared a state of emergency this weekend, media reported, closing all schools and cracking down on public gatherings, after several deaths linked to a measles outbreak that has spread across the Pacific islands. The island state of just 200,000, located south of the equator and half way between Hawaii and New Zealand, declared a measles epidemic late in October after the first deaths were reported. Since then, at least six deaths, five of them of infants under the age of two, have been linked to the outbreak,... ...
WELLINGTON (Reuters) - New Zealand lawmakers passed a bill on Wednesday that would legalize euthanasia, paving the way for the public to vote on the issue in a referendum next year. FILE PHOTO: A pedestrian walks past the New Zealand parliament building known as the Beehive in central Wellington, New Zealand, July 3, 2017. REUTERS/David Gray/File Photo The bill, which enables terminally ill people to request a medically assisted death, was passed 69-51 in parliament, after several amendments and years of heated debate. Previous atte... ...
(Reuters) - Celgene Corp’s treatment for anemia in patients with beta thalassemia, a rare blood disorder, would be priced at $3,441 for a 25-milligram vial of the drug, partner Acceleron Pharma Inc said. The U.S. Food and Drug Administration approved the treatment, Reblozyl, on Friday. The drug was jointly developed by Acceleron and Celgene, which is being bought by Bristol-Myers Squibb Co. A typical dose of Reblozyl consists of 1 mg of the drug for a kilogram of patient’s weight. A 75 mg vial of Reblozyl will be available at a whol... ...
WASHINGTON (Reuters) - Pharmaceutical supplier Fagron Holding USA LLC will pay $22.5 million to resolve allegations that its subsidiaries inflated average wholesale prices for compound drug ingredients and submitted fraudulent claims to federal healthcare programs, the U.S. Department of Justice said on Thursday. The settlement will resolve legal actions filed against Fagron units Freedom Pharmaceuticals, B&B pharmaceuticals and Pharmacy Services Inc, the department said in a statement. Fagron Holding is owned by Belgium’s Fagron NV. ... ...
While it’s important to wash your hands carefully after handling raw chicken, it may be even more important to wash them after going to the bathroom. The most dangerous antibiotic-resistant strains of E. coli, called ESBLs, are transmitted not through food, according to new research, but through contact of human feces with human mouths. British researchers examined many strains of ESBL-E. coli in human blood and feces, sewage, farm slurry, live animals, and raw meat, fruits and vegetables. They found that one multidrug-resistant strai... ...
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble BENGALURU (Reuters) - Indian drugmaker Sun Pharmaceutical Industries Ltd said on Wednesday it would introduce some of its cancer treatment drugs in China through Britain’s AstraZeneca. This comes after AstraZeneca said it was launching a new fund with China International Capital Corp to invest $1 billion in China’s healthcare sector, as it expands its research work in the country. Sun Pharma will be responsible fo... ...
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo (Reuters) - AstraZeneca Plc said on Monday a combination of its cancer drug, Imfinzi, along with chemotherapy helped curb progression of lung cancer in a late-stage study, sending its shares up 2%. The combination, when added to the drugmaker’s tremelimumab therapy, also met the secondary goal of improving progression-free ... ...
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo (Reuters) - AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer. The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when comp... ...